Lipophilic Statins and Risk for Hepatocellular Carcinoma and Death in Patients With Chronic Viral Hepatitis: Results From a Nationwide Swedish Population.
Simon, Tracey G
Lipophilic Statins and Risk for Hepatocellular Carcinoma and Death in Patients With Chronic Viral Hepatitis: Results From a Nationwide Swedish Population. [electronic resource] - Annals of internal medicine 09 2019 - 318-327 p. digital
Publication Type: Journal Article
1539-3704
10.7326/M18-2753 doi
Carcinoma, Hepatocellular--epidemiology
Cause of Death
Dose-Response Relationship, Drug
Duration of Therapy
Hepatitis B, Chronic--complications
Hepatitis C, Chronic--complications
Humans
Hydrophobic and Hydrophilic Interactions
Hydroxymethylglutaryl-CoA Reductase Inhibitors--pharmacology
Incidence
Lipid Metabolism--drug effects
Liver Neoplasms--epidemiology
Propensity Score
Registries
Risk Factors
Sweden--epidemiology
Lipophilic Statins and Risk for Hepatocellular Carcinoma and Death in Patients With Chronic Viral Hepatitis: Results From a Nationwide Swedish Population. [electronic resource] - Annals of internal medicine 09 2019 - 318-327 p. digital
Publication Type: Journal Article
1539-3704
10.7326/M18-2753 doi
Carcinoma, Hepatocellular--epidemiology
Cause of Death
Dose-Response Relationship, Drug
Duration of Therapy
Hepatitis B, Chronic--complications
Hepatitis C, Chronic--complications
Humans
Hydrophobic and Hydrophilic Interactions
Hydroxymethylglutaryl-CoA Reductase Inhibitors--pharmacology
Incidence
Lipid Metabolism--drug effects
Liver Neoplasms--epidemiology
Propensity Score
Registries
Risk Factors
Sweden--epidemiology